Hoelzer D - Search Results

1

[Intensive combined therapy for high-risk ALL patients].

Hoelzer D, Thiel E, Löffler H, Büchner T, Ganser A, Heil G, Kurrle E, Heimpel H, Koch P, Lipp T, et al. Hoelzer D, et al. Onkologie. 1988 Feb;11(1):18-24. doi: 10.1159/000216474. Onkologie. 1988. PMID: 3283621 Clinical Trial. German.

2

[Induction and intensive combined therapy of acute myeloid leukemia in adults].

Kurrle E, Ehninger G, Freund M, Heil G, Hoelzer D, Link H, Mitrou PS, Ohl S, Queisser W, Schlimok G, et al. Kurrle E, et al. Among authors: hoelzer d. Onkologie. 1988 Feb;11(1):5-9. doi: 10.1159/000216470. Onkologie. 1988. PMID: 3283626 German.

3

Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults.

Hoelzer D, Thiel E, Löffler H, Büchner T, Ganser A, Heil G, Koch P, Freund M, Diedrich H, Rühl H, et al. Hoelzer D, et al. Blood. 1988 Jan;71(1):123-31. Blood. 1988. PMID: 3422030 Free article.

4

TAD-induction therapy for 175 adults with acute myeloid leukemia, followed by consolidation and maintenance therapy. The joint study of Ulm and Tübingen.

Link H, Kurrle E, Frauer HM, Heil G, Heimpel H, Waller HD, Ostendorf P, Wilms K, Hoelzer D. Link H, et al. Among authors: hoelzer d. Onkologie. 1986 Jun;9(3):135-8. doi: 10.1159/000215985. Onkologie. 1986. PMID: 3528958

5

Age adapted induction and intensified consolidation therapy in acute myelogenous leukemia.

Kurrle E, Ehninger G, Freund M, Heil G, Hoelzer D, Link H, Mitrou PS. Kurrle E, et al. Among authors: hoelzer d. Onkologie. 1986 Jun;9(3):141-3. doi: 10.1159/000215987. Onkologie. 1986. PMID: 3528959

6

[Recruiting patients and results of a preliminary study on the therapy of acute lymphatic leukemia and acute undifferentiated leukemia in adults].

Hoelzer D, Thiel E, Löffler H, Bodenstein H, Plaumann L, Büchner T, Urbanitz D, Koch P, Heimpel H, Engelhardt R, et al. Hoelzer D, et al. Onkologie. 1983 Aug;6(4):170-4. doi: 10.1159/000215227. Onkologie. 1983. PMID: 6355944 Clinical Trial. German.

7

[Acute lymphatic leukemia of the adult. Diagnosis, risk groups and therapy].

Hoelzer D, Gökbuget N, Arnold R, Büchner T, Freund M, Gassmann W, Heil G, Hiddemann W, Löffler H, Lipp T, Ludwig WD, Maschmeyer G, Thiel E, Messerer D. Hoelzer D, et al. Internist (Berl). 1996 Oct;37(10):994-1007. Internist (Berl). 1996. PMID: 9019457 Review. German. No abstract available.

8

Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML).

Ganser A, Heil G, Seipelt G, Hofmann W, Fischer JT, Langer W, Brockhaus W, Kolbe K, Ittel TH, Brack N, Fuhr HG, Knuth P, Höffken K, Bergmann L, Hoelzer D. Ganser A, et al. Among authors: hoelzer d. Ann Hematol. 2000 Jan;79(1):30-5. doi: 10.1007/s002770050005. Ann Hematol. 2000. PMID: 10663618 Clinical Trial.

9

[Effectiveness of gnotobiotic measures in the treatment of acute leukemia: the results of a prospective randomized clinical study].

Dietrich M, Abt C, Arnold R, Pflieger H, Hoelzer D, Kurrle E, Rasche H, Kubanek B, Heimpel H, Fliedner TM. Dietrich M, et al. Among authors: hoelzer d. Onkologie. 1979 Jun;2(3):102-7. doi: 10.1159/000214484. Onkologie. 1979. PMID: 392375 Clinical Trial. German.

10

Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine arabinoside in patients with myelodysplastic syndrome. A pilot study.

Ganser A, Ottmann OG, Schulz G, Hoelzer D. Ganser A, et al. Among authors: hoelzer d. Onkologie. 1989 Feb;12(1):13-5. doi: 10.1159/000216589. Onkologie. 1989. PMID: 2654786

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

675 results

Search Page

Filters